{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T17:22:04Z","timestamp":1772040124212,"version":"3.50.1"},"reference-count":0,"publisher":"Bentham Science Publishers Ltd.","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CDTIA"],"published-print":{"date-parts":[[2004,3,1]]},"DOI":"10.2174\/1568010043483890","type":"journal-article","created":{"date-parts":[[2005,3,24]],"date-time":"2005-03-24T19:10:19Z","timestamp":1111691419000},"page":"87-96","source":"Crossref","is-referenced-by-count":32,"title":["The Possibilities and Pitfalls for Anti-Complement Therapies in Inflammatory Diseases"],"prefix":"10.2174","volume":"3","author":[{"given":"M.","family":"Mizuno","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","container-title":["Current Drug Target -Inflammation & Allergy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/91427","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2015,11,23]],"date-time":"2015-11-23T05:04:28Z","timestamp":1448255068000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/openurl\/content.php?genre=article&issn=1568-010X&volume=3&issue=1&spage=87"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,3,1]]},"references-count":0,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2004,3,1]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1568010043483890","relation":{},"ISSN":["1568-010X"],"issn-type":[{"value":"1568-010X","type":"print"}],"subject":[],"published":{"date-parts":[[2004,3,1]]}}}